Jonathan Saltzman

Jonathan Saltzman is a member of the Globe’s Spotlight Team. He has more than two decades of journalism experience. He previously worked for WBUR and WRNI, the NPR stations in Massachusetts and Rhode Island. Before that, he was a reporter at the Providence Journal.

Latest stories

Heard in the halls of biotech: I’ll meet you in the Valium room.

By , Globe Staff

Developing drugs is a serious business, but many Massachusetts biotechs go for the quirky when they name meeting rooms.

Takeda again sweetens its offer for Shire

By , Globe Staff

Japanese drug maker now says it’s willing to pay about $62 billion for the Irish-based biotech, which is run out of Massachusetts.

Two Cambridge biotechs settle dispute over alleged theft of trade secrets

By , Globe Staff

Without admitting wrongdoing, Dicerna will pay much its larger rival Alnylam $15 million plus stock to resolve litigation.

Shire rejects Takeda’s $60 billion takeover bid

By , Globe Staff

The Irish drug maker, which has most of its operations in Massachusetts, rejected an offer that would have made Japan’s Takeda one of the biggest drug makers in the world.